Paper29106905
Characterisation of endogenous A2A and A2B receptor-mediated cyclic AMP responses in HEK 293 cells using the GloSensor™ biosensor: Evidence for an allosteric mechanism of action for the A2B-selective antagonist PSB 603.
Goulding J and 2 others. Biochem Pharmacol, 2018. Cited by 30 papers, by iCite.
Cite this record
ConductScience Library. Characterisation of endogenous A2A and A2B receptor-mediated cyclic AMP responses in HEK 293 cells using the GloSensor™ biosensor: Evidence for an allosteric mechanism of action for the A2B-selective antagonist PSB 603. Papers, record 29106905. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/29106905
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
Characterisation of endogenous A2A and A2B receptor-mediated cyclic AMP responses in HEK 293 cells using the GloSensor™ biosensor: Evidence for an allosteric mechanism of action for the A2B-selective antagonist PSB 603.
- PubMed
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Adenosine A2 Receptor Antagonists | Major topic |
| Biosensing Techniques | Major topic |
| Cyclic AMP | Major topic |
| Receptor, Adenosine A2A | Major topic |
| Receptor, Adenosine A2B | Major topic |
| Sulfonamides | Major topic |
| Xanthines | Major topic |
| Allosteric Regulation | |
| Dose-Response Relationship, Drug | |
| HEK293 Cells | |
| Humans |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| G0800006 | Medical Research Council | United Kingdom | PubMed |
Source PubMed
References41
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 23286920 | Ligand-specific binding and activation of the human adenosine A(2B) receptor. | Biochemistry | 2013 | https://conductscience.org/library/papers/23286920 | PubMed |
| 2 | 18832607 | The 2.6 angstrom crystal structure of a human A2A adenosine receptor bound to an antagonist. | Science | 2008 | https://conductscience.org/library/papers/18832607 | PubMed |
| 3 | 7582508 | The in vitro pharmacology of ZM 241385, a potent, non-xanthine A2a selective adenosine receptor antagonist. | Br J Pharmacol | 1995 | https://conductscience.org/library/papers/7582508 | PubMed |
| 4 | 21303899 | International Union of Basic and Clinical Pharmacology. LXXXI. Nomenclature and classification of adenosine receptors--an update. | Pharmacol Rev | 2011 | https://conductscience.org/library/papers/21303899 | PubMed |
| 5 | 16841096 | Role of A2B adenosine receptor signaling in adenosine-dependent pulmonary inflammation and injury. | J Clin Invest | 2006 | https://conductscience.org/library/papers/16841096 | PubMed |
| 6 | 8632302 | The non-xanthine heterocyclic compound SCH 58261 is a new potent and selective A2a adenosine receptor antagonist. | J Pharmacol Exp Ther | 1996 | https://conductscience.org/library/papers/8632302 | PubMed |
| 7 | 19569717 | 1-alkyl-8-(piperazine-1-sulfonyl)phenylxanthines: development and characterization of adenosine A2B receptor antagonists and a new radioligand with subnanomolar affinity and subtype specificity. | J Med Chem | 2009 | https://conductscience.org/library/papers/19569717 | PubMed |
| 8 | 18570354 | Novel genetically encoded biosensors using firefly luciferase. | ACS Chem Biol | 2008 | https://conductscience.org/library/papers/18570354 | PubMed |
| 9 | 23515162 | Conformational biosensors reveal GPCR signalling from endosomes. | Nature | 2013 | https://conductscience.org/library/papers/23515162 | PubMed |
| 10 | 20637785 | Allosteric modulation of G protein-coupled receptors: a pharmacological perspective. | Neuropharmacology | 2011 | https://conductscience.org/library/papers/20637785 | PubMed |
| 11 | 16844405 | Adenosine A(2b) receptor is highly expressed in human hepatocellular carcinoma. | Hepatol Res | 2006 | https://conductscience.org/library/papers/16844405 | PubMed |
| 12 | 17009927 | Allosteric modulation of G protein-coupled receptors. | Annu Rev Pharmacol Toxicol | 2007 | https://conductscience.org/library/papers/17009927 | PubMed |
| 13 | 9933143 | Comparison of CGS 15943, ZM 241385 and SCH 58261 as antagonists at human adenosine receptors. | Naunyn Schmiedebergs Arch Pharmacol | 1999 | https://conductscience.org/library/papers/9933143 | PubMed |
| 14 | 21185259 | Recent developments in adenosine receptor ligands and their potential as novel drugs. | Biochim Biophys Acta | 2011 | https://conductscience.org/library/papers/21185259 | PubMed |
| 15 | 18568423 | Progress in the discovery of selective, high affinity A(2B) adenosine receptor antagonists as clinical candidates. | Purinergic Signal | 2009 | https://conductscience.org/library/papers/18568423 | PubMed |
| 16 | 24633424 | BAY60-6583 acts as a partial agonist at adenosine A2B receptors. | J Pharmacol Exp Ther | 2014 | https://conductscience.org/library/papers/24633424 | PubMed |
| 17 | 10393547 | Characterization of G protein-coupled receptor regulation in antisense mRNA-expressing cells with reduced arrestin levels. | Biochemistry | 1999 | https://conductscience.org/library/papers/10393547 | PubMed |
| 18 | 26824742 | Discovery of Potent and Highly Selective A2B Adenosine Receptor Antagonist Chemotypes. | J Med Chem | 2016 | https://conductscience.org/library/papers/26824742 | PubMed |
| 19 | 20694793 | Efficacy is a contributing factor to the clinical onset of bronchodilation of inhaled beta(2)-adrenoceptor agonists. | Naunyn Schmiedebergs Arch Pharmacol | 2010 | https://conductscience.org/library/papers/20694793 | PubMed |
| 20 | 9459566 | Comparative pharmacology of human adenosine receptor subtypes - characterization of stably transfected receptors in CHO cells. | Naunyn Schmiedebergs Arch Pharmacol | 1998 | https://conductscience.org/library/papers/9459566 | PubMed |
Cited by25
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 30 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42806985 | Dual blockade of adenosine A2A and A2B receptors is required to reverse NECA-induced immunosuppression in human macrophages: Implications for cancer immunotherapy. | Front Immunol | 2026 | https://conductscience.org/library/papers/42806985 | PubMed |
| 42650775 | Characterising C-X-C Chemokine Receptor 4 Dynamics in the Cell Membrane Using Fluorescence Fluctuation Spectroscopy. | Biomolecules | 2026 | https://conductscience.org/library/papers/42650775 | PubMed |
| 39437713 | Size-reduced DREADD derivatives for AAV-assisted multimodal chemogenetic control of neuronal activity and behavior. | Cell Rep Methods | 2024 | https://conductscience.org/library/papers/39437713 | PubMed |
| 39179957 | Ectopically expressed rhodopsin is not sensitive to X-rays. | BMC Neurosci | 2024 | https://conductscience.org/library/papers/39179957 | PubMed |
| 39031734 | A novel and selective fluorescent ligand for the study of adenosine A2B receptors. | Pharmacol Res Perspect | 2024 | https://conductscience.org/library/papers/39031734 | PubMed |
| 38928239 | Hair Thickness Growth Effect of Adenosine Complex in Male-/Female-Patterned Hair Loss via Inhibition of Androgen Receptor Signaling. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/38928239 | PubMed |
| 38833181 | A2B adenosine receptor signaling and regulation. | Purinergic Signal | 2025 | https://conductscience.org/library/papers/38833181 | PubMed |
| 38580813 | Mechano-sensitivity of β2-adrenoceptors enhances constitutive activation of cAMP generation that is inhibited by inverse agonists. | Commun Biol | 2024 | https://conductscience.org/library/papers/38580813 | PubMed |
| 38474167 | Real-Time Determination of Intracellular cAMP Reveals Functional Coupling of Gs Protein to the Melatonin MT1 Receptor. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/38474167 | PubMed |
| 38403442 | Engineering CREB-activated promoters for adenosine-induced gene expression. | Biotechnol J | 2024 | https://conductscience.org/library/papers/38403442 | PubMed |
| 37569749 | Ivy Leaf Dry Extract EA 575® Has an Inhibitory Effect on the Signalling Cascade of Adenosine Receptor A2B. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37569749 | PubMed |
| 37186850 | A self-inactivating invertebrate opsin optically drives biased signaling toward Gβγ-dependent ion channel modulation. | Proc Natl Acad Sci U S A | 2023 | https://conductscience.org/library/papers/37186850 | PubMed |
| 36657828 | Human adenylyl cyclase 9 is auto-stimulated by its isoform-specific C-terminal domain. | Life Sci Alliance | 2023 | https://conductscience.org/library/papers/36657828 | PubMed |
| 36495270 | Kinetic analysis of endogenous β2 -adrenoceptor-mediated cAMP GloSensor™ responses in HEK293 cells. | Br J Pharmacol | 2023 | https://conductscience.org/library/papers/36495270 | PubMed |
| 36278183 | Update on the recent development of allosteric modulators for adenosine receptors and their therapeutic applications. | Front Pharmacol | 2022 | https://conductscience.org/library/papers/36278183 | PubMed |
| 35970889 | Chimeric GPCRs mimic distinct signaling pathways and modulate microglia responses. | Nat Commun | 2022 | https://conductscience.org/library/papers/35970889 | PubMed |
| 35408582 | Anti-Hair Loss Effect of Adenosine Is Exerted by cAMP Mediated Wnt/β-Catenin Pathway Stimulation via Modulation of Gsk3β Activity in Cultured Human Dermal Papilla Cells. | Molecules | 2022 | https://conductscience.org/library/papers/35408582 | PubMed |
| 35230706 | Regionally selective cardiovascular responses to adenosine A2A and A2B receptor activation. | FASEB J | 2022 | https://conductscience.org/library/papers/35230706 | PubMed |
| 34070360 | Adenosine and Cordycepin Accelerate Tissue Remodeling Process through Adenosine Receptor Mediated Wnt/β-Catenin Pathway Stimulation by Regulating GSK3b Activity. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/34070360 | PubMed |
| 33801503 | Molecular and Pharmacological Characterization of the Interaction between Human Geranylgeranyltransferase Type I and Ras-Related Protein Rap1B. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/33801503 | PubMed |
Genes5
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ADA | 100 | PubTator's text mining | https://conductscience.org/library/genes/100 | NCBI Gene |
| ADORA2B | 136 | PubTator's text mining | https://conductscience.org/library/genes/136 | NCBI Gene |
| GRK2 | 156 | PubTator's text mining | https://conductscience.org/library/genes/156 | NCBI Gene |
| IGKV2D-29 | 28882 | PubTator's text mining | https://conductscience.org/library/genes/28882 | NCBI Gene |
| SUCNR1 | 56670 | PubTator's text mining | https://conductscience.org/library/genes/56670 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/29106905
GET https://conductscience.org/api/papers/v1/29106905/references?page=2